Wird geladen...
Efficacy of icotinib in advanced lung squamous cell carcinoma
BACKGROUND: There are controversial data supporting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with advanced lung squamous cell carcinoma (SCC). In this study, the efficacy of icotinib in unselected and EGFR‐mutated patients with lung SCC wa...
Gespeichert in:
| Veröffentlicht in: | Cancer Med |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6143949/ https://ncbi.nlm.nih.gov/pubmed/30109777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1736 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|